Autopsy report · NCT03946462

Nitric Oxide During CPB to Reduce AKI in Neonates

“This study could not be started because of some technical issues.”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Phase 1

Sponsor

Fabio Savorgnan

Sponsor type

University, hospital or other

Conditions

Congenital Heart Disease; Acute Kidney Injury

Interventions

NO gas delivered during cardiac surgery; placebo gas delivered during cardiac surgery

Participants

0

Sites

1

Countries

United States

Trials that died the same way

• Study of Brain Tumors (Tectal Tumors) Using Magnetic Resonance Imaging
  “There were technical difficulties and the study was terminated in 2008” (70% match in meaning)
• Effect of Rasagiline on Balance in Parkinson's Disease as Measured by Computerized Posturography
  “Funding for the study could not be obtained.” (69% match in meaning)
• Oral Treprostinil in Subjects With Pulmonary Hypertension Associated With Pulmonary Fibrosis
  “Study design was inadequate and would not achieve study endpoints” (68% match in meaning)
• Remote Trial - Tobacco Product Standard (VLNC)
  “Study determined to be not feasible at this time due to limited availability of study product and limited availability of study products in the marketplace.” (68% match in meaning)
• Efficacy Study of Fluconazole to Treat Coccidioidomycosis Pneumonia (Valley Fever)
  “Study terminated due to lack of feasibility of study design.” (67% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.